Cargando…
PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429351/ http://dx.doi.org/10.1097/01.HS9.0000977232.29155.a4 |
| _version_ | 1785090690885091328 |
|---|---|
| author | Cooper, Nichola Cuker, Adam Michel, Marc Wong, Raymond Ghanima, Waleed Zaja, Francesco Barcellini, Wilma Zhang, Fengkui Lawniczek, Tomasz Weill, Marine Al-Samkari, Hanny |
| author_facet | Cooper, Nichola Cuker, Adam Michel, Marc Wong, Raymond Ghanima, Waleed Zaja, Francesco Barcellini, Wilma Zhang, Fengkui Lawniczek, Tomasz Weill, Marine Al-Samkari, Hanny |
| author_sort | Cooper, Nichola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429351 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293512023-08-17 PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) Cooper, Nichola Cuker, Adam Michel, Marc Wong, Raymond Ghanima, Waleed Zaja, Francesco Barcellini, Wilma Zhang, Fengkui Lawniczek, Tomasz Weill, Marine Al-Samkari, Hanny Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429351/ http://dx.doi.org/10.1097/01.HS9.0000977232.29155.a4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Cooper, Nichola Cuker, Adam Michel, Marc Wong, Raymond Ghanima, Waleed Zaja, Francesco Barcellini, Wilma Zhang, Fengkui Lawniczek, Tomasz Weill, Marine Al-Samkari, Hanny PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| title | PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| title_full | PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| title_fullStr | PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| title_full_unstemmed | PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| title_short | PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| title_sort | pb2636: vayhit1: a multicenter, randomized, double-blind, phase iii trial of ianalumab versus placebo in addition to first-line corticosteroids in patients with primary immune thrombocytopenia (itp) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429351/ http://dx.doi.org/10.1097/01.HS9.0000977232.29155.a4 |
| work_keys_str_mv | AT coopernichola pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT cukeradam pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT michelmarc pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT wongraymond pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT ghanimawaleed pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT zajafrancesco pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT barcelliniwilma pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT zhangfengkui pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT lawniczektomasz pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT weillmarine pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp AT alsamkarihanny pb2636vayhit1amulticenterrandomizeddoubleblindphaseiiitrialofianalumabversusplaceboinadditiontofirstlinecorticosteroidsinpatientswithprimaryimmunethrombocytopeniaitp |